The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Using single-cell sequencing to identify endothelial expression of immune checkpoint ligands in advanced hepatocellular carcinoma, pre- and post- atezolizumab plus bevacizumab in the phase II INTEGRATE study.
 
Florence Wu
Honoraria - Bristol-Myers Squibb
 
Jehan Vakharia
No Relationships to Disclose
 
Stephanie Wong
No Relationships to Disclose
 
Adriana Vukosich
No Relationships to Disclose
 
Selina Melillo
No Relationships to Disclose
 
Leo Chan
No Relationships to Disclose
 
Giselle Boukhaled
No Relationships to Disclose
 
Simone Stone
Research Funding - EMD Serono (Inst)
 
Azin Sayad
No Relationships to Disclose
 
Ben Wang
No Relationships to Disclose
 
Harry Harvey
No Relationships to Disclose
 
Cathy Yan
No Relationships to Disclose
 
Marco Marra
No Relationships to Disclose
 
Pamela Ohashi
No Relationships to Disclose
 
Rachel Garonce-Hediger
Employment - F. Hoffmann LaRoche
Stock and Other Ownership Interests - F. Hoffmann LaRoche
Travel, Accommodations, Expenses - F. Hoffmann LaRoche
 
Raymond Jang
Research Funding - AstraZeneca (Inst); Camurus (Inst); Merck (Inst)
 
Robert Grant
Consulting or Advisory Role - AstraZeneca; Eisai; Guardant Health; Incyte; Ipsen; Knight Therapeutics
Research Funding - Pfizer
 
Eric Chen
Honoraria - AstraZeneca Canada; Eisai; GlaxoSmithKline; Merck; Pfizer; Roche; Takeda
Research Funding - 1Globe Health Institute; AstraZeneca/MedImmune; Bristol-Myers Squibb; GlaxoSmithKline; Janssen Oncology; Merck Sharp & Dohme; Mirati Therapeutics; Novartis; Repare Therapeutics; Roche Canada
 
Jennifer Knox
Honoraria - AstraZeneca; Incyte; Ipsen
Consulting or Advisory Role - AstraZeneca/MedImmune; Incyte; Ipsen
Research Funding - AstraZeneca; Ipsen; Merck
Expert Testimony - AstraZeneca; Incyte
 
Adrian Sacher
Research Funding - Amgen (Inst); AstraZeneca (Inst); BMS (Inst); Bridgebio (Inst); CRISPR Therapeutics (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Hotspot Therapeutics (Inst); Iovance Biotherapeutics (Inst); Lilly Loxo (Inst); Merck (Inst); Pfizer (Inst); Spectrum Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Amgen; Genentech/Roche; Merck
(OPTIONAL) Uncompensated Relationships - Amgen; Genentech/Roche; Merck